Destination: This competitive grant program seeks to support research conducted by Junior Investigators that advances medical knowledge in the understanding, diagnosis and treatment of ATTR Amyloidosis. Pfizer is interested in supporting research proposals that advance our understanding of the epidemiology, basic science and early diagnosis and treatment of ATTR amyloidosis.
Budget: Up to $75.000/year.
Duration: 1-2 years.
Llena el siguiente formulario para recibir más información: